These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15942435)

  • 21. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
    Kumar MU; Swamy K; Supe SS; Anantha N
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience.
    Shioyama Y; Nakamura K; Sasaki T; Ooga S; Urashima Y; Kimura M; Uehara S; Terashima H; Honda H
    Am J Clin Oncol; 2005 Feb; 28(1):75-80. PubMed ID: 15685039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus.
    Hareyama M; Nishio M; Kagami Y; Narimatsu N; Saito A; Sakurai T
    Int J Radiat Oncol Biol Phys; 1992; 24(2):235-40. PubMed ID: 1526861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy for esophageal cancer in patients over 80 years old.
    Yamakawa M; Shiojima K; Takahashi M; Saito Y; Matsumoto H; Mitsuhashi N; Niibe H
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1225-32. PubMed ID: 7525520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.
    Tessa M; Rotta P; Ragona R; Sola B; Grassini M; Nassisi D; Sciacero P; Airoldi M; Filippi A; Gianello L; De Angelis C; Ozzello F; Trotti AB; Ricardi U; Sannazzari GL
    Tumori; 2005; 91(5):406-14. PubMed ID: 16459637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results.
    Ishikawa H; Nonaka T; Sakurai H; Tamaki Y; Kitamoto Y; Ebara T; Shioya M; Noda SE; Shirai K; Suzuki Y; Takahashi T; Nakano T
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):452-9. PubMed ID: 19419819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.
    Ordu AD; Nieder C; Geinitz H; Scherer V; Kup PG; Schuster T; Combs SE; Fakhrian K
    Anticancer Res; 2014 Dec; 34(12):7255-61. PubMed ID: 25503157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S;
    Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
    Muijs CT; Beukema JC; Mul VE; Plukker JT; Sijtsema NM; Langendijk JA
    Radiother Oncol; 2012 Feb; 102(2):303-8. PubMed ID: 21885139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.
    Nishimura Y; Okuno Y; Ono K; Mitsumori M; Nagata Y; Hiraoka M
    Cancer; 1999 Jul; 86(2):220-8. PubMed ID: 10421257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
    Martínez-Monge R; Pagola Divassón M; Cambeiro M; Gaztañaga M; Moreno M; Arbea L; Montesdeoca N; Alcalde J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e245-54. PubMed ID: 21620582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.